How is ARK Genomic Revolution ETF (ARKG) doing?

ARK Genomic Revolution ETF is an exchange-traded fund. Here is how it has done against the market, and where it shows up on our dashboards.

Updated Oct 9, 2026

market beat

Strong

ARK Genomic Revolution ETF shares are up 60% over the past year, 38 points ahead of the S&P 500. Among large US stocks and funds it ranks in the 93rd percentile on market beat and the 82nd on staying power. It appears on 1 of our dashboards, including 1st on “Which themes are working?”.

$51.30+60% in a yearWorth $1.8B

Financials, earnings and news on Stox ›

Past year

The past year

Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.

ARKG against the S&P 500, past year

$100 a year ago. ARK Genomic Revolution ETF +60%, the S&P 500 +16%.

ARKGS&P 500

How is it doing against its group?

Its group is Spec growth, 67 large US stocks and funds whose prices tend to move together. High-beta growth, fintech and disruption — the risk-on extreme.

ARKG, past year+60%1 of 67 in the group

Rest of the group−20%equal-weighted

S&P 500+16%past year

ARK Genomic Revolution ETF is +60% over the past year, against −20% for the rest of the group and +16% for the S&P 500. It ranks 1st of 67 in Spec growth.

ARKGRest of the group

Best in the groupROKU Roku+53%SPHB Invesco S&P 500 High Beta ETF+36%FRPT Freshpet+29%

Worst in the groupLCID Lucid Motors−83%UWMC United Wholesale Mortgage−80%TTD Trade Desk−78%

Spec growth on Stox ›

How much does it move?

Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.

About usual ARK Genomic Revolution ETF typically moves 4.5% in a day, about usual for it, and it swings more than 96% of large US funds.

Typical day4.5%about $2.31 a share

Its usual3.9%about usual, 1.2× its year’s average

Against the S&P 5003.5×the index’s typical day is 1.1%

Unusual day±9.0%twice its typical day

Deepest fall, past year−28%now 10% below its high

In the S&P’s down weeks175%of the index’s fall, three years; beta 1.7

Typical daily move (ATR)Its year’s average 3.86%

ARKG on our dashboards

Every question where ARK Genomic Revolution ETF appears, in the order of the home page, with its reading and place in that table. Select a question to open it with ARKG highlighted. Select a column to sort.

Question	Reading	Place	Details
Which themes are working? Funds and commodities	100Leading	1 of 14	vs S&P, 1M +10.3 pts · 3M +20.4 pts · 1Y +44 pts

Go deeper on Stox

ARKG’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.

Open ARKG on Stox ›Its group on Stox ›

How to read this page

How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.

Sources. Daily prices from Financial Modeling Prep.

Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.

Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.

Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.

For financial statements, earnings and news, see ARKG’s full profile on Stox.

This page is information, not investment advice. About our data and methods ›

Full profile on Stox ›